User Fee Sticking Points, AdvaMed Hire, China Clinical Trial Policy
In this week’s Pathways Picks: Sticking points and progress from FDA-industry MDUFA VI talks; FDA veteran Melissa Torres takes top regulatory spot at AdvaMed; FDA eyes 510(k) exemptions; China expands devices requiring national approval to start clinical trials; and more updates from the US, EU, and UK.